Headquartered in Antwerp, Belgium, with an additional site in Denmark (Aarhus). The company is developing macrophage-targeted ...
Swiss pharma giant Novartis’ (NOVN; VX) has announced results showing that one in four patients with hormone ...
Vinay Prasad, director of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), ...
The European Commission has approved Roche’s Gazyva/Gazyvaro (obinutuzumab) in combination with mycophenolate mofetil (MMF) ...
Sanegene Bio has raised more than $110 million in a series B round to move its RNAi programs toward registration studies and ...
Ascletis Pharma (HKEX: 1672) has reported positive topline results from a 13-week Phase II study of ASC30, its once-daily oral GLP-1 agonist for obesity. All three doses met the primary endpoint with ...
GSK (LSE: GSK) has chosen to unwind its synthetic lethality alliance with US biotech Ideaya Biosciences (Nasdaq: IDYA), ...
Roche (ROG: SIX) has unveiled a fresh wave of data for Lunsumio (mosunetuzumab), underscoring the Swiss pharma major’s ...
Kallyope is preparing to move its oral migraine candidate elismetrep toward registrational development after the TRPM8 ...
China is making significant strides in CAR-T innovation. Recently, Chongqing Precision Biotech received approval for Priligy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback